BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 37082790)

  • 1. A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
    Nakatani K; Noborio R; Nomura Y; Ueki Y; Kiyohara T; Hashimoto T
    J Dermatol; 2024 Jan; ():. PubMed ID: 38214494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.
    Zhou X; Zhou Y; Qian H; Wu F; Liu H; Li X; Li W
    J Dermatol; 2023 Oct; 50(10):e354-e356. PubMed ID: 37341162
    [No Abstract]   [Full Text] [Related]  

  • 3. Indirect immunofluorescence for bullous pemphigoid using ex vivo confocal laser scanning microscopy.
    Bağcı IS; Ergün EZ; Avci P; Aoki R; Krammer S; Vladimirova G; Sárdy M; Ruzicka T; Hartmann D
    J Dermatol; 2023 Aug; 50(8):e236-e237. PubMed ID: 36914975
    [No Abstract]   [Full Text] [Related]  

  • 4. Dietary habits in Japanese patients with bullous pemphigoid: low intake of retinol.
    Uozumi T; Serizawa N; Hagino T; Morita T; Mizuno M; Ichiyama S; Hoashi T; Saeki H; Matsuda H; Nakagawa K; Mitsui H; Kanda N
    Eur J Dermatol; 2023 Aug; 33(4):394-403. PubMed ID: 37823490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Psoriasis and Bullous Diseases.
    Dainichi T; Kabashima K
    Front Med (Lausanne); 2018; 5():222. PubMed ID: 30135860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit.
    Goletz S; Probst C; Komorowski L; Radzimski C; Mindorf S; Holtsche MM; Pigors M; van Beek N; Zillikens D; Schlumberger W; Schmidt E
    Br J Dermatol; 2024 Mar; ():. PubMed ID: 38544457
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment with guselkumab of anti-p200 pemphigoid associated with plaque psoriasis.
    Kitayama S; Makino T; Kataoka K; Mori S; Takemoto K; Furukawa F; Torai R; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
    J Dtsch Dermatol Ges; 2024 Apr; ():. PubMed ID: 38593343
    [No Abstract]   [Full Text] [Related]  

  • 8. Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid.
    Goletz S; Pigors M; Lari TR; Hammers CM; Wang Y; Emtenani S; Aumailley M; Holtsche MM; Stang FH; Weyers I; König IR; Has C; Radzimski C; Komorowski L; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2024 Apr; 90(4):790-797. PubMed ID: 37992812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid.
    Kitayama S; Makino T; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
    J Dermatol; 2023 Sep; 50(9):1194-1198. PubMed ID: 37082790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA anti-p200 pemphigoid.
    Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
    Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-p200 pemphigoid.
    Goletz S; Hashimoto T; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-p200 pemphigoid].
    Holtsche MM; Goletz S; Zillikens D
    Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.